We sought to determine the linkage to and retention in HIV care after HIV diagnosis in foreign-born compared with US-born individuals. From a clinical data registry, we identified 619 patients aged ≥18 years with a new HIV diagnosis between 2000 and 2012. Timely linkage to care was the proportion of patients with an ICD-9 code for HIV infection (V08 or 042) associated with a primary care or infectious disease physician within 90 days of the index positive HIV test. Retention in HIV care was the presence of an HIV primary care visit in each 6-month period of the 24-month measurement period from the index HIV test. We used Cox regression analysis with adjustment for hypothesized confounders (age, gender, race/ethnicity, substance abuse, year, and location of HIV diagnosis). Foreign-born individuals comprised 36% (225/619) of the cohort. Index CD4 count was 225/µl (IQR 67-439/µl) in foreign-born compared with 328/µl (IQR 121-527/µl) in US-born individuals (p < .001). The proportion linked to care was 87% (196/225) in foreign-born compared with 77% (302/394) in US-born individuals (p = .002). The adjusted hazard ratio of linkage to HIV care in foreign-born compared with US-born individuals was 1.28 (95% confidence interval [CI], 1.05-1.56). Once linked, there was no difference in retention in care or virologic suppression at 24 months. These results show that despite late presentation to HIV care, foreign-born persons can subsequently engage in HIV care as well as US-born persons. Interventions that promote HIV screening in foreign-born persons are a promising way to improve outcomes in these populations.
Introduction
Virologic suppression and survival are predicated on engagement in HIV care, defined as the uptake of HIV testing and linkage to and retention in consistent HIV primary care (Giordano et al., 2007; Ulett et al., 2009) . Despite the importance of engagement in HIV care, only three-quarters of HIV-diagnosed persons in the USA are linked to care within 90 days of diagnosis and one-half are retained in care (Bradley et al., 2014; Gray et al., 2014) . Lower outcomes of linkage to and retention in HIV care are found in racial and ethnic minorities and are important targets to address disparities in HIV outcomes (Bradley et al., 2014) .
Foreign-born persons, many of whom are racial and ethnic minorities, represent an understudied but rising subset of the US population disproportionately affected by the HIV epidemic. Foreign-born individuals comprise 13% of the US population but 16% of new HIV infections (Prosser, Tang, & Hall, 2012) . HIV-infected foreign-born individuals tend to be younger, present with more advanced infection, and progress to AIDS faster than their native-born counterparts (Johnson, Hu, & Dean, 2010; Marc et al., 2010; Antiretroviral Therapy Cohort C [ARTCC] et al., 2013; Staehelin et al., 2003) .
Our objective was to characterize linkage, retention, and virologic suppression in foreign-born compared with US-born HIV-infected individuals. We hypothesized that HIV-infected foreign-born persons are less likely to link to HIV care in a timely way compared with US-born persons.
area (Massachusetts General Hospital Disparities Solution Center and MGH/MGPO Center for Quality and Safety, 2014) . HIV care is provided in primary care practices and two hospital-based HIV clinics. Clinical data points are derived from hospital electronic medical records (EMRs), administrative databases, and billing data.
Exposure characterization
The eligible cohort (n = 1170) included all patients newly diagnosed with HIV infection (Figure 1) . "Newly diagnosed" patients were those whose last HIV test was positive (index test) between 2000 and 2012. HIV tests included were enzyme immunoassay, direct antigen, Western Blot, and rapid antibody tests, for HIV-1 and HIV-2. We excluded 551 patients ( Figure 1 ). Eleven were aged <18 years. To distinguish between new HIV diagnoses and confirmatory testing, we determined the duration of prior contact with our healthcare system. We categorized individuals with ≥30 days between the first clinical encounter and a positive HIV test as a new diagnosis. We reviewed the medical records of all 355 patients with <30 days follow-up prior to the index test and excluded 236 where the test represented confirmation of HIV infection. Consistent with a validated algorithm to identify new HIV diagnoses from the EMR, we excluded 304 who had a CD4 count or HIV viral load >90 days before the index HIV test (Goetz, Hoang, Kan, Rimland, & Rodriguez-Barradas, 2014) . The final cohort constituted 619 persons.
Place of birth was determined using a previously validated algorithm that combines a coded field for primary language spoken with computer-aided review of free text notes (Levison et al., 2014) . We considered a patient as US born if the place of birth was documented as US mainland, Puerto Rico, or other US territory (United States Census Bureau, 2013) .
Data elements
The primary outcomes were linkage to and retention in HIV care as defined by the U.S. Department of Health and Human Services (DHHS) (Mugavero, Davila, Nevin, & Giordano, 2010; U.S. DHHS Health Resources and Services Administration, 2015) . Timely linkage to care was the presence of an encounter with a primary care or infectious disease physician ≤90 days from the index test that resulted in a billing code for HIV infection (ICD-9 code V08 or 042). We examined an alternate definition of linkage to care where the HIV-coded encounter occurred ≤30 days from the index test. Patients were considered retained in HIV care if they had a visit in each 6-month interval of the 24-month period following the index HIV test, with the visit in each 6-month interval separated by ≥60 days. We calculated the proportion retained and limited the denominator to those with ≥1 HIV medical visit in the first 6 months of the 24-month measurement period, consistent with DHHS reporting practice. The secondary outcome was virologic suppression. We calculated the proportion of patients with HIV RNA <400 copies/ml using the closest HIV RNA to the 24-month mark within a 3-month range (21-27 months) (Horberg et al., 2010;  Panel on Antiretroviral Guidelines for Adults and Adolescents, 2015).
We evaluated a priori covariates hypothesized as predictors of HIV care utilization: place of birth (foreign compared with US born), age (per decade), year and location (inpatient vs. outpatient) of index HIV test, race/ethnicity, gender, history of substance abuse, and index CD4. Self-identified race and ethnicity were obtained from the EMR and were categorized as White, Black, Hispanic, Asian, and Other (including American Indian and unknown). Substance abuse or dependence was categorized separately for alcohol, opioid, and cocaine and/or amphetamine and defined by the presence of an ICD-9 code or coded problem list in the EMR. In order to categorize year at HIV diagnosis, we performed a bivariate analysis between calendar year of diagnosis and linkage to care. The years 2000 and 2001 had a statistically significant lower linkage to care. Therefore, we categorized year of diagnosis as 2000-2001, 2002-2006, and 2007-2012 when state-mandated health insurance took effect. We evaluated the index CD4 dated 30 days before to 100 days after the index HIV test.
Statistical analysis
We compared estimates of timely linkage to and retention in HIV care in the foreign-born and US-born cohorts using a chi-square test. We assessed the relationship between the aforementioned hypothesized predictors and time to linkage using Cox proportional hazards models with linkage censored at 90 days from the index HIV test. Because CD4 counts were often not obtained at the time of diagnosis, we defined index CD4 as the first CD4 count obtained within 100 days of the HIV test. This definition has the effect of confounding the availability of index CD4 with the outcome of linkage to care. For this reason, we did not include index CD4 in the multivariable model of linkage to care. We explored the impact of various factors (location of diagnosis, gender, nativity, and linkage to care) on having an index CD4 using chi-squared tests. We used multivariable logistic regression of the dichotomous outcome of retention in care, and adjusted for hypothesized predictors, which included index CD4 as a marker of baseline disease severity. We present adjusted hazard ratios (AHR) and adjusted odds ratios (AOR) with 95% confidence intervals (CI).
Statistical tests were two sided with a significance level of .05. We assessed differences in demographic and clinical characteristics between foreign-born and US-born patients using chi-squared tests for categorical data and Wilcoxon ranksum tests and t-tests for continuous data. All statistical analyses were performed using Stata (StataCorp, 2013.) . This study was approved by the Partners HealthCare Institutional Review Board (Boston, MA).
Results

Cohort description
We identified 619 individuals with a new HIV diagnosis between 2000 and 2012 and 36% (n = 225) were foreign born ( Table 1 ). The mean age was 41 years [SD ± 10.6 years] and did not differ between the two groups. Foreign-born were more likely to be female (n = 74, 33%) compared with US-born patients (n = 88, 22%) (p = .004). In foreign-born compared to US-born patients, there was a higher percentage of Blacks (40% vs. 23%) and Hispanics (33% vs. 10%) (p < .001). Inpatient HIV diagnosis occurred in 29% (n = 66) of foreignborn and 26% (n = 102) of US-born patients (p = .35). Substance abuse was more common in the US-born group, with alcohol abuse present in 25% (n = 98), opioid in 12% (n = 49), and cocaine/methamphetamine in 15% (n = 61). In the foreign-born group, alcohol abuse was present in 9% (n = 20), opioid abuse in 2% (n = 4), and cocaine/methamphetamine in 5% (n = 11) (p < .001).
Of the 619 individuals, 579 had an available index CD4 cell count, of whom 92% (364/394) were US born and 95% (215/225) were foreign born, p = .12. The median index CD4 count in newly diagnosed foreignborn patients was 225 cells/µl [IQR 67-439/µl] compared with 328 cells/µl [IQR 121-527/µl] in US-born patients (p = .0003). When stratified by gender, median index CD4 count for foreign-born males was 190 cells/ µl [IQR 57-401]); foreign-born females was 286 cells/µl Leading up to diagnosis, there was no significant difference in the frequency of HIV testing in this health system between foreign-born and US-born individuals (p = .28), and 76% (n = 473) of all individuals had one HIV test.
Of the 607/619 individuals who had language data coded in the hospital database, 40% (87/221) of the foreign-born cohort identified as primary non-Englishlanguage speakers. Spanish was the primary language in 61% (53/87) of this group. Other frequent non-English languages were Portuguese, French and Haitian Creole, and Cambodian.
As of 2013, there were 71 known deaths. Thirty-seven deaths occurred within 24 months of HIV diagnosis and 12 deaths occurred within the first 90 days. There was no difference in deaths by place of birth.
Linkage to care
The proportion of individuals with timely linkage to HIV care in the US-born group was 77% (302/394) [95% CI 72-81%] compared with 87% (196/225) [95% CI 82-91%] in the foreign-born group, p = .002. In the alternate definition of linkage to care, where timely linkage represented a primary care HIV encounter <30 days from HIV diagnosis, the result was similar where the proportion of US born linked to HIV care was 66% (260/ 394) [95% CI 61-71%] vs. 74% (166/225) [95% CI 67-80%] in the foreign-born group, p = .04. When stratified by gender and place of birth, the percent with timely linkage to care was 67% [95% CI 57-76%] for US-born females, 79% [95% CI 74-84%] for US-born males, 80% [95% CI 69-87%] for foreign-born females, and 91% [95% CI 85-94%] for foreign-born males. Of the 619 patients, 58 never returned for outpatient HIV care: 13% (n = 50) of US-born and 4% (n = 8) of foreign-born patients (p < .001).
In the Cox model, the AHR of linkage to care in foreign-born compared with US-born individuals was 1.28 (95% CI, 1.05-1.56) ( Table 2) . Females (AHR = 0.73; 95% CI, 0.59-0.90), those diagnosed with opioid abuse disorder (AHR = 0.58; 95% CI, 0.39-0.86), those diagnosed with HIV as an outpatient (AHR = 0.56; 95% CI, 0.45-0.69), and those diagnosed in the years 2000-2001 (AHR = 0.34; 95% CI, 0.24-0.48), had longer time to linkage to HIV care. Age; race/ethnicity; alcohol or cocaine abuse; and the years 2007-2012, when statemandated health insurance took effect, compared with 2002-2006, were not significantly associated with linkage to care.
Having an index CD4 count measurement available was associated with being diagnosed with HIV as an inpatient and, as expected, with timely linkage to care. Of those individuals who received an HIV diagnosis as an inpatient, 97% (163/168) had an index CD4 count, compared with 92% (416/451) in those who were diagnosed as an outpatient (p = .03). Those with timely linkage to care were more likely to have had an index CD4 count compared to those who did not link to care within 90 days (84% vs. 25%, p < .001) and a lower index CD4 count (median: 278 cells/µl [IQR: 82-500] vs. 388 cells/ µl [IQR: 181-581], p = .002). These CD4 count trends were consistent in both US-born and foreign-born groups.
Retention in care
After excluding 11 individuals with <24 months of follow-up and 91 without an HIV visit in the first 6month period, 517 patients were included in the retention analysis. At 24 months, 69% (355/517) met the DHHS definition of continuous retention in care. In the US-born individuals, 67% (210/313) [95% 61-73%] were retained in HIV care for 24 months compared with 71% (145/204) [95% CI 64-77] of foreign-born individuals (p = 0.34). In a logistic regression model adjusting for predefined covariates, continuous retention in care for 24 months was associated with White race (AOR = 1.72; 95% CI, 1.09-2.71) and a lower index CD4 (AOR 0.95; 95% CI, 0.92-0.99) (Table 3) .
Virologic suppression
Of the 355 individuals retained in care at 24 months, 285 had a viral load (HIV RNA) available, of whom 58% (n = 164) were US born and 42% (n = 121) were foreign born, p = .21. Overall, 84% (n = 240) of the cohort had virologic suppression (HIV RNA <400 copies/ml). Virologic suppression was present in 82% of US-born (134/164) and 88% of foreign-born individuals (106/121), p = .177.
Discussion
Foreign-born individuals, a rapidly growing part of the US population, contribute a disproportionally high number of new HIV cases and may be at higher risk for poor HIV outcomes (Prosser et al., 2012) . Foreign-born patients are also difficult to identify and study on a population level, as country of origin is typically excluded from the EMR. We employed a validated algorithm to identify, characterize, and follow HIV-infected foreignborn patients in a large urban healthcare system (Levison et al., 2014) . Compared with US-born, newly infected foreign-born individuals presented to HIV primary care with lower CD4 counts, levels comparable to many resource-limited settings (Braitstein et al., 2006; Nash et al., 2008) . A lower index CD4 count itself is a prognostic factor for AIDS and death (Antiretroviral Therapy Cohort, 2007) . The difference in index CD4 count between foreign-born and US-born individuals represents an estimated 1-2-year delay in HIV diagnosis in foreign-born individuals (Lang et al., 1989) . While foreign-born patients entered HIV care with more advanced disease, they were at least as engaged and adherent to care as the US-born group.
The earlier linkage to care that we observed in the foreign-born group was contrary to our hypothesis and the findings of another large study on linkage to care, by Torian et al., that used New York City Department of Health surveillance data (Torian, Wiewel, Liu, Sackoff, & Frieden, 2008) . Since index CD4 count was substantially lower in the foreign-born cohort, we hypothesize that foreign-born individuals linked to care more quickly than US-born individuals due to more symptomatic disease at diagnosis and a greater perceived need for HIV care. In the multivariable model, we also found that a higher index CD4 decreased the odds of retention in care. The absence of symptomatic disease has been described in multiple settings as an important barrier to the uptake of HIV care (Johnston et al., 2013; Turner et al., 2000) .
A lower index CD4 count in the foreign-born group likely relates to delays in HIV diagnosis. We suspect that even prior to entering our healthcare system, unequal barriers to HIV testing due to perceived need, stigma, fear of deportation, and lack of a regular healthcare provider may have contributed to the disparity in baseline disease severity (De Jesus, Carrete, Maine, & Nalls, 2015; Hacker et al., 2011; Levy et al., 2007; Ojikutu, Nnaji, Sithole-Berk, Bogart, & Gona, 2014; Ransome et al., 2015) . While US Immigration and Customs Enforcement detention facilities house nearly 32,000 immigrants per day, HIV screening is not routine (Martinez-Donate et al., 2015; Venters, McNeely, & Keller, 2009 ). This public health practice departs from the guidance of the DHHS and the National Commission on Correctional Health Care, who both endorse universal opt-out testing, and may serve as an important impediment to HIV diagnosis and linkage to care in foreign-born individuals (National Commission on Correctional Health Care, 2014; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2015; U.S. Immigration and Customs Enforcement, 2011). Since substance abuse treatment centers in the USA are important sites for HIV counseling and testing, the higher prevalence of substance abuse history in the USborn group may represent greater opportunities for HIV testing and earlier diagnosis (Pollack & D'Aunno, 2010) .
Once delays in presentation to HIV care were overcome through linkage to care, we found no difference in retention in HIV care or virologic suppression in foreign-born compared with US-born persons, a finding supported in several cohorts (Breton et al., 2007; Poon, Dang, Davila, Hartman, & Giordano, 2013; Staehelin et al., 2003) . Unmeasured protective factors that may support engagement in HIV care in foreign-born persons include social support and cultural values that prioritize the family and community well-being (Perez & Cruess, 2014; Remien et al., 2015) .
Women in our study were less likely than men to link to care. In both US-and foreign-born cohorts, the index CD4 count was higher in women than men. EuroCoord, a large European collaboration of HIV cohorts, reported elevated mortality risk in HIV-infected migrant women that was related to the mode of HIV transmission and country of origin (Migrants Working Group on behalf of Cohere in EuroCoord, 2015) . Together these data suggest that women face ongoing barriers to HIV care that can influence women's perceived need for HIV care, particularly when the disease is asymptomatic. Factors such as limited access to care, trauma, and family responsibilities may increase the risk for poor HIV outcomes in women (Aziz & Smith, 2011; Metsch et al., 2015) . Linkage to HIV care was not significantly different in the years 2007-2012 compared with 2002-2006, the period before state healthcare reform. This finding is consistent with a prior study that found that access to universal health insurance in Massachusetts improved insurance coverage but did not address language and other cultural factors that perpetuate health disparities (Maxwell, Cortes, Schneider, Graves, & Rosman, 2011) .
This analysis has several limitations. The algorithm used to identify new HIV diagnoses may be subject to misclassification, though we attempted to address this by EMR review and including those with documented incident HIV infection. Some potentially important socio-demographic factors were unavailable (e.g., residency status, income, HIV transmission category, and insurance and country of origin data for all patients). Documentation of transfer of care was unavailable as data were drawn from an open healthcare system. Substance abuse may be undercounted with ICD-9 coding. Not all patients had available CD4 and viral load data, though there were no differences in the proportion of missing data between foreign-born and US-born individuals.
These results identify an addressable gap in the HIV treatment cascade of foreign-born HIV-infected individuals: given their likelihood of remaining in care once diagnosed, interventions to promote earlier HIV diagnosis of foreign-born individuals may portend improved clinical outcomes.
